PROTOSTAT Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Protostat, and what generic alternatives are available?
Protostat is a drug marketed by Ortho Mcneil Pharm and is included in one NDA.
The generic ingredient in PROTOSTAT is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Protostat
A generic version of PROTOSTAT was approved as metronidazole by TEVA PHARMS USA on November 6th, 1984.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PROTOSTAT?
- What are the global sales for PROTOSTAT?
- What is Average Wholesale Price for PROTOSTAT?
Summary for PROTOSTAT
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 172 |
| Patent Applications: | 2,064 |
| DailyMed Link: | PROTOSTAT at DailyMed |
US Patents and Regulatory Information for PROTOSTAT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ortho Mcneil Pharm | PROTOSTAT | metronidazole | TABLET;ORAL | 018871-001 | Mar 2, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Ortho Mcneil Pharm | PROTOSTAT | metronidazole | TABLET;ORAL | 018871-002 | Mar 2, 1983 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
